Menu
GWAS Study

Genetic determinants of lung cancer prognosis in never smokers: A pooled analysis in the International Lung Cancer Consortium.

Brhane Y, Yang P, Christiani DC et al.

32699080 PubMed ID
GWAS Study Type
2456 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

BY
Brhane Y
YP
Yang P
CD
Christiani DC
LG
Liu G
MJ
McLaughlin JR
BP
Brennan P
SS
Shete S
FJ
Field JK
TA
Tardón A
KT
Kohno T
SK
Shiraishi K
MK
Matsuo K
BY
Bossé Y
AC
Amos CI
HR
Hung RJ
Chapter II

Abstract

Summary of the research findings

Lung cancer remains the leading cause of cancer death worldwide, with 15% to 20% occurring in never smokers. To assess genetic determinants for prognosis among never smokers, we conducted a genome-wide investigation in the International Lung Cancer Consortium (ILCCO).

1,569 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

2456
Total Participants
GWAS
Study Type
Yes
Replicated
887 Japanese ancestry individuals
Replication Participants
European, East Asian
Ancestry
Canada, U.S., Japan
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.